Physician profile
James Rodriguez
NPI 1265494678
$535.39
in general payments reported to CMS, 2019-2025
16 companies · $83.06 in 2025
The $83.06 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $30.76 · 2022: $15.61 · 2023: $197 · 2024: $84.76 · 2025: $83.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $84.39 | 2019-2024 | Doc Band |
| Merck Sharp & Dohme LLC | $75.13 | 2019-2023 | Gardasil 9, Vaxelis, M-M-R II |
| Kyowa Kirin, INC. | $49.64 | 2023 | Crysvita |
| Sanofi-Aventis U.S. LLC | $48.66 | 2024 | |
| Acadia Pharmaceuticals INC | $47.24 | 2025 | Daybue |
| Sanofi Pasteur INC. | $41.22 | 2023-2025 | |
| Pfizer INC. | $39.78 | 2023-2024 | |
| Sobi, INC | $24.74 | 2023 | |
| Ironshore Pharmaceuticals INC. | $19.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.73 | 2023 | Flumist Quadrivalent |
| Genentech USA, INC. | $18.65 | 2019 | |
| Abbvie INC. | $14.98 | 2021 | |
| Cipher Pharmaceuticals US LLC | $14.74 | 2025 | Natroba, Spinosad |
| Amneal Pharmaceuticals LLC | $13.11 | 2019 | |
| Philips North America LLC | $12.30 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.